Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

NCT00233636 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer
Carcinoma, Squamous Cell

Interventions

DRUG: Iressa (Gefitinib)
PROCEDURE: Radiotherapy

Sponsor

AstraZeneca